Physician

Asad Majid, M.D.

According to 2025 Medicare claims, Asad Majid, M.D. (NPI: 1982778254) practices nephrology in the Appleton, WI market, with the plurality of this provider's patient population coming from Outagamie, WI. This provider's primary affiliated billing organization is FOX VALLEY NEPHROLOGY PARTNERS S C (NPI: 1891713756; TIN: 201741300) and primary practice location at 54130-9560. Majid is affiliated with the Mercy Health Corporation (ACO ID: A2097), HSHS ACO, L.L.C. (ACO ID: A2783), and THEDACARE ACO (ACO ID: A4988), participating under the MSSP model.

Majid's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 325 traditional Medicare patients, billed 1,058 HCPCS/CPT codes, and received $123,192 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 1,173 prescription claims across 281 beneficiaries totaling $161,494 in drug costs, led by Xphozah (Tenapanor Hcl). 2019 DME data shows 69 claims. Open Payments data shows 58 records totaling $1,240. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $338,414 to $161,494. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $5,794 to $341.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	610	1,859	$165,739
2016	624	1,676	$162,626
2017	422	1,411	$151,843
2018	498	1,596	$168,901
2019	521	1,568	$158,412
2020	531	1,397	$136,260
2021	393	1,333	$133,245
2022	399	1,132	$134,535
2023	400	1,166	$130,030
2024	325	1,058	$123,192

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	491	6,709	$338,414
2016	434	7,156	$414,366
2017	290	2,983	$236,769
2018	232	902	$65,079
2019	157	394	$23,425
2020	209	664	$38,345
2021	199	764	$88,015
2022	248	974	$103,516
2023	271	1,032	$133,452
2024	281	1,173	$161,494

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	62	$2,632
2016	N/R	35	$230
2017	N/R	31	$231
2018	N/R	69	$3,512
2019	N/R	69	$3,878
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	38	38	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	45	49	$88
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	43	67	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	45	57	$60
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	101	181	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xphozah	Tenapanor Hcl	14	540	$52,126
Renvela	Sevelamer Carbonate	13	601	$22,849
Auryxia	Ferric Citrate	11	330	$13,918
Sevelamer Carbonate	Sevelamer Carbonate	99	5,684	$12,658
Calcitriol	Calcitriol	221	16,744	$4,101

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	58	$1,240	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Asad Majid, M.D.?

Tedicare shows public-source Medicare data for Asad Majid, M.D. (NPI 1982778254), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Asad Majid, M.D. have ACO affiliation data?

Asad Majid, M.D. is shown with ACO affiliation data for Mercy Health Corporation (MSSP, ACO ID A2097), HSHS ACO, L.L.C. (MSSP, ACO ID A2783), and THEDACARE ACO (MSSP, ACO ID A4988).

What billing organization is linked to Asad Majid, M.D.?

Asad Majid, M.D. is linked to FOX VALLEY NEPHROLOGY PARTNERS S C (billing NPI 1891713756) in the available physician profile data.

Does Asad Majid, M.D. have Open Payments data?

Asad Majid, M.D. has 58 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.